Vetmust Pharma Private Limited
Founded in 2017 and headquartered in Haryana, India.
2017 | Faridabad, Haryana (India) | Active
Vetmust Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 0.19%
- Profit Growth 22.89%
- Ebitda 79.87%
- Net Worth 20.14%
- Total Assets 33.53%
About Vetmust Pharma
Vetmust Pharma Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 August 2017 (Seven years and six months 26 days old ). Its registered office is in Faridabad, Haryana, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Deep Mala and Suman Devi serve as directors at the Company.
Company Details
- Location
Faridabad, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999HR2017PTC070190
- Company No.
070190
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Aug 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Business Services
Who are the key members and board of directors at Vetmust Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deep Mala  | Director | 03-Aug-2017 | Current |
| Suman Devi | Director | 03-Aug-2017 | Current |
Financial Performance of Vetmust Pharma.
Vetmust Pharma Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 0.19% increase. The company also saw a substantial improvement in profitability, with a 22.89% increase in profit. The company's net worth Soared by an impressive increase of 20.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vetmust Pharma?
Unlock access to Vetmust Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vetmust Pharma?
Unlock and access historical data on people associated with Vetmust Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vetmust Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vetmust Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.